Cargando…
Defining information fractions in group sequential clinical trials with multiple endpoints
The group sequential design has been well understood and widely applied in designs of late phase clinical trial to enable potentially early stopping for efficacy or futility. The information fraction (IF) is one of the key elements to determine the decision boundary at the interim analyses. The fami...
Autores principales: | Xu, Tu, Qin, Qin, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898546/ https://www.ncbi.nlm.nih.gov/pubmed/29696161 http://dx.doi.org/10.1016/j.conctc.2018.03.005 |
Ejemplares similares
-
Choice of futility boundaries for group sequential designs with two endpoints
por: Schüler, Svenja, et al.
Publicado: (2017) -
Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
por: Jeeyapant, Atthanee, et al.
Publicado: (2017) -
Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups
por: Lee, Ji-Hyun, et al.
Publicado: (2009) -
Informative noncompliance in endpoint trials
por: Snapinn, Steven M, et al.
Publicado: (2004) -
Group-sequential clinical trials with multiple co-objectives
por: Hamasaki, Toshimitsu, et al.
Publicado: (2016)